Amanote Research

Amanote Research

    RegisterSign In

Role of the STK15 Phe31Ile Polymorphism in Renal Cell Carcinoma

Oncology Reports - Greece
doi 10.3892/or.17.1.3
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineCancer ResearchOncology
Date

January 1, 2007

Authors
Christine HammerschmiedRobert StoehrBernhard WalterWolf WielandArndt HartmannHagen BlaszykStefan Denzinger
Publisher

Spandidos Publications


Related search

The Role of Surgery in Renal Cell Carcinoma With Pancreatic Metastasis

Biomedical Journal
Medicine
2015English

Association of Vitamin D Receptor Gene Polymorphism With Renal Cell Carcinoma in Japanese.

Endocrine Journal
EndocrinologyMetabolismDiabetes
2002English

The Expression and Role of Tyrosine Kinase ETK/BMX in Renal Cell Carcinoma

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

The Contemporary Role of Lymph Node Dissection in the Management of Renal Cell Carcinoma

Therapeutic Advances in Urology
Urology
2018English

Current Perspectives in Metastatic Renal Cell Carcinoma Treatment: The Role of Targeted Therapies

2013English

Renal Cell Carcinoma

World Journal of Urology
Urology
2016English

Germline Polymorphism of Interferon-Lambda3 Is Clinically Associated With Progression of Renal Cell Carcinoma

Oncotarget
Oncology
2017English

Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?

Clinical Medicine Insights: Oncology
Oncology
2011English

Renal Cell Carcinoma

Japanese Journal of Urology
Urology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy